Carter Boyd
Family Medicine · Bossier City, LANPI 1982713483
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 481 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,501 and has fallen 93.3% since, to $100 in 2024.
Across 481 payments — averaging $11.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$798
- Amgen$630
- Shire North American Group Inc$411
- Lilly USA, LLC$317
- plus $1K from 19 others
What the payments were for
- Food & beverage$5,626100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 89 | $1,071 |
| AbbVie(2 entities) | 154 | $1,004 |
| Takeda Pharmaceuticals U.S.A., Inc. | 92 | $798 |
| Amgen(2 entities) | 49 | $630 |
| Shire North American Group Inc | 25 | $411 |
| Lilly USA, LLC | 21 | $317 |
| Boehringer Ingelheim | 25 | $250 |
| Axogen | 1 | $212 |
| Kerecis Limited | 1 | $147 |
| Sientra, Inc. | 1 | $143 |
| Acell, Inc. | 1 | $141 |
| Acumed LLC | 1 | $100 |
| Hikma Pharmaceuticals USA | 4 | $85 |
| Avanir Pharmaceuticals, Inc. | 5 | $72 |
| Ironshore Pharmaceuticals Inc. | 1 | $37 |
| Evoke Pharma, Inc. | 2 | $37 |
| Bayer | 1 | $25 |
| Eyevance Pharmaceuticals LLC | 1 | $24 |
| Halozyme Inc | 1 | $22 |
| Mylan Specialty L.p. | 1 | $22 |
| Zyla Life Sciences, Inc. | 1 | $19 |
| AstraZeneca | 1 | $17 |
| Medtronic | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
| Avion Pharmaceuticals | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,631 in reported general payments places this provider in the 85th percentile of 1,469 family medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 38 | $341 |
| Potassium Chloride | 19 | $338 |
| Atorvastatin Calcium | 50 | $323 |
| Gabapentin | 15 | $303 |
| Amlodipine Besylate | 37 | $243 |
| Levothyroxine Sodium | 29 | $223 |
| Montelukast Sodium | 30 | $222 |
| Pantoprazole Sodium | 20 | $173 |
| Omeprazole | 15 | $146 |
| Metoprolol Succinate | 14 | $141 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 15 | $103 |
| Lisinopril | 12 | $84 |
| Glipizide | 13 | $82 |
| Metoprolol Tartrate | 14 | $76 |
| Furosemide | 15 | $73 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bossier City
- Clint WilsonBossier City$16K
- Jason MilliganBossier City$15K
- Michael AngeloBossier City$15K
- Christine SmithBaton Rouge$185K
- Thomas DansbyMonroe$169K
- Michael FlemingShreveport$165K
- Robert St AmantGonzales$156K
- William HathawaySpringhill$105K
- Cesar GonzalesWest Monroe$94K
- Phillip ConnerSulphur$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.